Abstract
BACKGROUND AND AIM: MIS-C is a hyperinflammatory syndrome caused by Sars-CoV-2 virus. Cardiovascular system impairment is observed up to 100 % of all MIS-C patients with a wide spectrum and severity of symptoms. It is important to identify the course of the disease and its outcome, which could significantly improve public health.
METHODS: A single-centre study, prospective cohort study, conducted in the Children’s Clinical University hospital in Latvia from January to December 2021. Patients between the ages of one to seventeen years who met the MIS-C criteria were included in the study. We evaluated blood pressure, left ventricular heart function, size of coronary arteries and hospital course.
RESULTS: Thirty-one patients were included who met the MIS-C criteria. The median age was 8.0 years, 52% were boys. Of all patients 77% initially presented with hypotension of whom 42% required inotropic support. Treatment in PICU was required in 58% of all patients. Reduced left ventricular ejection fraction was observed in 35% of all patients. Mildly decreased ventricular ejection fraction (
METHODS: A single-centre study, prospective cohort study, conducted in the Children’s Clinical University hospital in Latvia from January to December 2021. Patients between the ages of one to seventeen years who met the MIS-C criteria were included in the study. We evaluated blood pressure, left ventricular heart function, size of coronary arteries and hospital course.
RESULTS: Thirty-one patients were included who met the MIS-C criteria. The median age was 8.0 years, 52% were boys. Of all patients 77% initially presented with hypotension of whom 42% required inotropic support. Treatment in PICU was required in 58% of all patients. Reduced left ventricular ejection fraction was observed in 35% of all patients. Mildly decreased ventricular ejection fraction (
Original language | English |
---|---|
Pages | 701 |
Number of pages | 1 |
Publication status | Published - 25 May 2022 |
Event | 55th Annual Meeting of the Association for European Pediatric and Congenital Cardiology (AEPC) - Geneva, Switzerland Duration: 25 May 2022 → 28 May 2022 Conference number: 55 https://www.aepc.org/aepc-annual-meeting https://conferencealerts.com/show-event?id=240395 |
Meeting
Meeting | 55th Annual Meeting of the Association for European Pediatric and Congenital Cardiology (AEPC) |
---|---|
Abbreviated title | AEPC 2022 |
Country/Territory | Switzerland |
City | Geneva |
Period | 25/05/22 → 28/05/22 |
Internet address |
Keywords*
- MIS-C
- Hypotension
- coronary artery dilation
Field of Science*
- 3.2 Clinical medicine
Publication Type*
- 3.4. Other publications in conference proceedings (including local)